Wilson Therapeutics Investors

29 investors on Angel Roster list Wilson Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, the United Kingdom and Sweden.

Investors are matched on the company name in their portfolio, so companies that share the name Wilson Therapeutics can appear together.

Investors listed
29
With verified email
38%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 29 Wilson Therapeutics investors

The most complete profiles first. Showing 29 of 29.

  • Chris JacksonVerified

    Venture Capital, Investor · United States

    SeedHealth CareE-commerceWomen FoundedLife Science

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Verified email available

  • Ken HaasVerified

    Venture Capital, Advisor, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • andrew sinclairVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Eric BednarskiVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Eric FritzVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Jason DoddVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Keith UnderwoodVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Verified email available

  • Kevin ChengVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Shelley ChuVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Stephen ReedersVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Stephen SmithVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Tim HainesVerified

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Bali Muralidhar

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more

    Contact details available

  • Brian Gallagher, Jr.

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more

    Contact details available

  • Kurt von Emster

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedInvestment ManagementLife Science

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Per Samuelsson

    Venture Capital, Private Equity Firm, Investor · Sweden

    SeedHealth CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Staffan Lindstrand

    Venture Capital, Private Equity Firm, Investor · Sweden

    SeedHealth CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Vin Miles

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Akhilesh Pathipati

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Hugo Harrod

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Jack Tanaka

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • John Heard

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Kyle Dempsey, MD, MBA

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Mary Shannon

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Neil Akhurst

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Nikki Matthews

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Sarah Shackelton

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Thomas Casdagli

    Venture Capital · United Kingdom

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Marten Steen

    Venture Capital, Investor · Sweden

    SeedHealth CareBiotechnologyMedicalTherapeutics

    Portfolio: FerroKin Biosciences, Priothera, Wilson Therapeutics

    Contact details available

Frequently asked questions

How many Wilson Therapeutics investors are on Angel Roster?

Angel Roster lists 29 Wilson Therapeutics investors. 11 of them (38%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (29), Private Equity Firms (14) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Wilson Therapeutics investors invest in?

Among those that list a stage, the most common are Series B (6) and Seed (4).

Where are Wilson Therapeutics investors based?

Most are based in the United States (17), the United Kingdom (9) and Sweden (3).

Which companies have Wilson Therapeutics investors backed?

The most-backed portfolio companies among them are Lombard Medical plc (22), Algeta (16), GenSight Biologics (16), Cytos (16) and Spruce Biosciences (16).

How do I contact Wilson Therapeutics investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.